Safety and Efficacy Study of PurTox® Botulinum Toxin Type A to Treat Frown Lines Between the Eyebrows
Status:
Completed
Trial end date:
2008-05-01
Target enrollment:
Participant gender:
Summary
The overall purpose of this study is to evaluate the safety and effectiveness of an
intramuscular dose of Mentor Purified Toxin for the reduction of frown lines, compared with
placebo.
Phase:
Phase 3
Details
Lead Sponsor:
Mentor Worldwide, LLC
Collaborator:
Quintiles, Inc.
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA